These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11693261

  • 1. MRNA and enzyme activity of hepatic 11beta-hydroxysteroid dehydrogenase type 1 are elevated in C57BL/KsJ-db/db mice.
    Aoki K, Homma M, Hirano T, Oka K, Satoh S, Mukasa K, Ito S, Sekihara H.
    Life Sci; 2001 Oct 12; 69(21):2543-9. PubMed ID: 11693261
    [Abstract] [Full Text] [Related]

  • 2. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice.
    Liu Y, Nakagawa Y, Wang Y, Li R, Li X, Ohzeki T, Friedman TC.
    Diabetes; 2003 Jun 12; 52(6):1409-16. PubMed ID: 12765951
    [Abstract] [Full Text] [Related]

  • 3. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice.
    Yuan X, Li H, Bai H, Zhao X, Zhang C, Liu H, Zhang Y, Zhao B, Wu Y, Liu J, Xiang Q, Feng B, Chu Y, Huang Y.
    Eur J Pharmacol; 2016 Oct 05; 788():140-151. PubMed ID: 27242185
    [Abstract] [Full Text] [Related]

  • 4. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
    Liu Y, Nakagawa Y, Wang Y, Sakurai R, Tripathi PV, Lutfy K, Friedman TC.
    Diabetes; 2005 Jan 05; 54(1):32-40. PubMed ID: 15616008
    [Abstract] [Full Text] [Related]

  • 5. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
    Liu Y, Nakagawa Y, Wang Y, Liu L, Du H, Wang W, Ren X, Lutfy K, Friedman TC.
    J Mol Endocrinol; 2008 Aug 05; 41(2):53-64. PubMed ID: 18524870
    [Abstract] [Full Text] [Related]

  • 6. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E, Cottrell EC, Keevil BG, DeSchoolmeester J, Bohlooly-Y M, Andersén H, Turnbull AV, Leighton B, White A.
    Endocrinology; 2013 Oct 05; 154(10):3599-609. PubMed ID: 23832962
    [Abstract] [Full Text] [Related]

  • 7. Liver-selective transgene rescue of hypothalamic-pituitary-adrenal axis dysfunction in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice.
    Paterson JM, Holmes MC, Kenyon CJ, Carter R, Mullins JJ, Seckl JR.
    Endocrinology; 2007 Mar 05; 148(3):961-6. PubMed ID: 17170103
    [Abstract] [Full Text] [Related]

  • 8. Regulation of 11beta-hydroxysteroid dehydrogenase type 1 and glucose-stimulated insulin secretion in pancreatic islets of Langerhans.
    Ortsäter H, Alberts P, Warpman U, Engblom LO, Abrahmsén L, Bergsten P.
    Diabetes Metab Res Rev; 2005 Mar 05; 21(4):359-66. PubMed ID: 15586384
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulation of 11beta-hydroxysteroid dehydrogenase enzymes by dietary sodium in the rat.
    McKinnell J, Roscoe D, Holmes MC, Lloyd-MacGilp SA, Kenyon CJ.
    Endocr Res; 2000 Feb 05; 26(1):81-95. PubMed ID: 10711725
    [Abstract] [Full Text] [Related]

  • 12. Time of the day for 11beta-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice.
    Véniant MM, Hale C, Komorowski R, Chen MM, St Jean DJ, Fotsch C, Wang M.
    Diabetes Obes Metab; 2009 Feb 05; 11(2):109-17. PubMed ID: 18479468
    [Abstract] [Full Text] [Related]

  • 13. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE, Walker BR.
    J Pharmacol Exp Ther; 2003 Apr 05; 305(1):167-72. PubMed ID: 12649365
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE.
    Metabolism; 2011 Dec 05; 60(12):1775-80. PubMed ID: 21704348
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.
    Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ.
    Proc Natl Acad Sci U S A; 2004 May 04; 101(18):7088-93. PubMed ID: 15118095
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1.
    Jamieson PM, Nyirenda MJ, Walker BR, Chapman KE, Seckl JR.
    J Endocrinol; 1999 Jan 04; 160(1):103-9. PubMed ID: 9854182
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
    Candia R, Riquelme A, Baudrand R, Carvajal CA, Morales M, Solís N, Pizarro M, Escalona A, Carrasco G, Boza C, Pérez G, Padilla O, Cerda J, Fardella CE, Arrese M.
    Liver Int; 2012 Mar 04; 32(3):392-9. PubMed ID: 22136330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.